Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
Histopathology|April 21, 2006
A new vision of tubular and tubulo-lobular carcinomas of the breast, as revealed by 3-D modellingC Marchiò, A Sapino, R Arisio, et al.Journal of Clinical Pathology|August 7, 2008
Hereditary breast cancer: from molecular pathology to tailored therapiesD S P Tan, C Marchiò, J S Reis-FilhoJournal of Clinical Pathology|July 22, 2008
Nestin is expressed in basal-like and triple negative breast cancersS Parry, K Savage, C Marchiò, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 15, 2010
Chemotherapy with or without trastuzumabC Oakman, A Sapino, C Marchiò, et al.The Journal of Pathology|September 13, 2008
ESR1 amplification in endometrial carcinomas: hope or hyperbole?D S P Tan, M B K Lambros, C Marchiò, et al.Virchows Archiv : an International Journal of Pathology|August 30, 2021
Triple-negative breast carcinomas of low malignant potential: review on diagnostic criteria and differential diagnosesL Cima, H Kaya, C Marchiò, et al.Journal of Clinical Pathology|August 7, 2007
Traditional urinary cytology and tyrosinase RT-PCR in metastatic melanoma patients: correlation with clinical statusP Savoia, S Osella-Abate, A Comessatti, et al.Breast (Edinburgh, Scotland)|June 28, 2026
What are the determinants of type of breast surgery following neoadjuvant chemotherapy? An analysis of breast cancer patients among Italian SENONET centers: NEOIMPACT studyA De Luca, M I Amabile, M Tomatis, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 30, 2025
Artificial intelligence entering the pathology arena in oncology: current applications and future perspectivesA Marra, S Morganti, F Pareja, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 4, 2019
ESMO recommendations on the standard methods to detect NTRK fusions in daily practice and clinical researchC Marchiò, M Scaltriti, M Ladanyi, et al.Pageof 2